Search

everythinglearnresearchcommunity

for

Search:↓

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The combination treatment showed a higher response rate but no significant survival benefits.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Removing a cat's pancreatic cancer can temporarily reverse hair loss caused by the disease.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Cetuximab can cause excessive eyelash growth.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Cetuximab can cause eyelash growth, which is rare but manageable.